Using the plaque assay or the CPE test (cytopathogenic effect), we investigated the action of human, simian (rhesus), bovine and murine interferons on bovine rotavirus adapted to grow on established Rhesus monkey kidney cell line (MA 104) or Georgia Bovine Kidney cell line (GBK). Except for the murine interferon we used, which had no antiviral effect at all, the different interferons tested were clearly active.
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Three strains of bovine rotavirus were used: a canadian strain PQ (kindly furnished by Dr. M. E. B6gin, St-Hyacinthe, Qudbec) and strains S t 4 and $77 isolated in our laboratory. They were grown on MA104 and GBK cells (1) . Vesicular Stomatitis Virus (VSV), originally obtained from Dr. Youngner (Pittsburgh), was produced in L929 cells.
H u m a n fibroblast interferon (Hu IFN~) was induced in FS4 cells of human foreskin fibroblasts by-poly inosinate-polycytidylate (poly I:C) as described by VIL6EK and HAVELL (8) and partially purified by ammonium sulfate precipitation and chromatography on Biogel P150 and CM Sephadex as described by K~mHT (3) . The specific activity of the preparation used throughout this work was 1 × 106 international units per mg of protein.
Mouse fibroblast interferon (Mu IFN~) was induced in L929 cells by NDV virus (Newcastle Disease Virus, Koumaroff strain). The purification of this interferon was achieved according to the method described by PAUCI~ER and STANCEK (6) . Its final specific activity was 1 × t06 international units per mg of protein.
Simian interferon (Rhesus IFN) was induced in MA 104 cells by infecting them with NDV (Koumaroff strain). The crude interferon, treated at p H 2 for at least 0304-8608/81/0070/0377]$ 01.00 five days, was used without further purification, after neutralization and clarification by centi~fugation.
For the production of bovine interferon (Boy IFN), GBK cells were induced with NDV (Koumaroff strain) and treated as the simian interferon.
The action of interferons on rotavi.rus was first tested on MA104 cells using the plaque assay described by MATSU~O et al. (5) and DAG~AIS et al. (2) . The cells were established in an antivirat state by incubation with I F N at 37 ° C overnight before inoculation with the bovine rotavirus. Then, the inhibitions by in~erferons of the cytopathogenic effect provoked either by VSV or by rotavirus were compared by the classical method using MA 104 and GBK cells.
According to our results, human, simian and bovine interferons are active on bovine rotavirus grown in established Rhesus monkey kidney or Georgia bovine kidney celt lines, whereas one partially purified murine interferon is not active at all. Compared with VSV, bovine rotavirus does not appear to be less susceptible to bovine interferon as it was reported by La Bonnardi~re and coworkers (4) . The choice of the experimental system is therefore important to ascribe the efficiency of interferon against bovine rotavirus in defined conditions. As the data obtained with the three strains of rotavirus are similar, Table 1 gives the comparison of the susceptibility to interferon of VSV and one strain of rota.virus.
The antiviral activity was destroyed by a pretreatment with trypsin and correlated well with the induction of 2'5' oligoisoadenytate synthetase (7). This indicates that interferon is the active factor involved in the antiviral effect.
Our preliminary results show that human fibroblast interferon (Hu I F N ~) has an important heterologous antiviral effect in GBK cells infected with bovine rotavirus. I t is therefore worthwhile to test the in vivo effect of human fibroblast interferon (Hu IFN~) on neonatal calf diarrhoea provoked by rotavirus. used, compared to the titer obtained in MA 104 cells using VSV as challenge virus. The mean of two independent, determinations are used to establish the comparison. Endpoints of titration are read as 50 per cent protection against CPE with a technique involving 0.5 log10 dilution steps. Reprodueible data have been obtained using dilutions of interferon preparations titrating between 102 and 104 laboratory units/mI
